• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于个性化肿瘤学的工作流程驱动的临床决策支持

Workflow-driven clinical decision support for personalized oncology.

作者信息

Bucur Anca, van Leeuwen Jasper, Christodoulou Nikolaos, Sigdel Kamana, Argyri Katerina, Koumakis Lefteris, Graf Norbert, Stamatakos Georgios

机构信息

Precision and Decentralized Diagnostics, Philips Research, Eindhoven, The Netherlands.

National Technical University of Athens, ICCS, Athens, Greece.

出版信息

BMC Med Inform Decis Mak. 2016 Jul 21;16 Suppl 2(Suppl 2):87. doi: 10.1186/s12911-016-0314-3.

DOI:10.1186/s12911-016-0314-3
PMID:27460182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4965727/
Abstract

BACKGROUND

The adoption in oncology of Clinical Decision Support (CDS) may help clinical users to efficiently deal with the high complexity of the domain, lead to improved patient outcomes, and reduce the current knowledge gap between clinical research and practice. While significant effort has been invested in the implementation of CDS, the uptake in the clinic has been limited. The barriers to adoption have been extensively discussed in the literature. In oncology, current CDS solutions are not able to support the complex decisions required for stratification and personalized treatment of patients and to keep up with the high rate of change in therapeutic options and knowledge.

RESULTS

To address these challenges, we propose a framework enabling efficient implementation of meaningful CDS that incorporates a large variety of clinical knowledge models to bring to the clinic comprehensive solutions leveraging the latest domain knowledge. We use both literature-based models and models built within the p-medicine project using the rich datasets from clinical trials and care provided by the clinical partners. The framework is open to the biomedical community, enabling reuse of deployed models by third-party CDS implementations and supporting collaboration among modelers, CDS implementers, biomedical researchers and clinicians. To increase adoption and cope with the complexity of patient management in oncology, we also support and leverage the clinical processes adhered to by healthcare organizations. We design an architecture that extends the CDS framework with workflow functionality. The clinical models are embedded in the workflow models and executed at the right time, when and where the recommendations are needed in the clinical process.

CONCLUSIONS

In this paper we present our CDS framework developed in p-medicine and the CDS implementation leveraging the framework. To support complex decisions, the framework relies on clinical models that encapsulate relevant clinical knowledge. Next to assisting the decisions, this solution supports by default (through modeling and implementation of workflows) the decision processes as well and exploits the knowledge embedded in those processes.

摘要

背景

临床决策支持(CDS)在肿瘤学中的应用可能有助于临床使用者有效应对该领域的高度复杂性,改善患者预后,并缩小临床研究与实践之间目前存在的知识差距。尽管在CDS的实施方面已投入大量精力,但在临床中的应用仍有限。文献中已广泛讨论了应用的障碍。在肿瘤学领域,当前的CDS解决方案无法支持患者分层和个性化治疗所需的复杂决策,也无法跟上治疗选择和知识的高更新率。

结果

为应对这些挑战,我们提出了一个框架,以实现有意义的CDS的高效实施,该框架纳入了多种临床知识模型,以利用最新领域知识为临床带来全面解决方案。我们既使用基于文献的模型,也使用在p-医学项目中利用来自临床试验的丰富数据集以及临床合作伙伴提供的护理所构建的模型。该框架对生物医学社区开放,允许第三方CDS实施重用已部署的模型,并支持建模人员、CDS实施人员、生物医学研究人员和临床医生之间的协作。为了提高应用率并应对肿瘤学中患者管理的复杂性,我们还支持并利用医疗保健组织所遵循的临床流程。我们设计了一种架构,通过工作流功能扩展CDS框架。临床模型嵌入到工作流模型中,并在临床过程中需要建议的时间和地点适时执行。

结论

在本文中,我们展示了在p-医学中开发的CDS框架以及利用该框架的CDS实施。为支持复杂决策,该框架依赖于封装相关临床知识的临床模型。除了协助决策外,此解决方案默认情况下(通过工作流的建模和实施)还支持决策过程,并利用这些过程中嵌入的知识。

相似文献

1
Workflow-driven clinical decision support for personalized oncology.用于个性化肿瘤学的工作流程驱动的临床决策支持
BMC Med Inform Decis Mak. 2016 Jul 21;16 Suppl 2(Suppl 2):87. doi: 10.1186/s12911-016-0314-3.
2
Bayesian approach to incorporating different types of biomedical knowledge bases into information retrieval systems for clinical decision support in precision medicine.贝叶斯方法在将不同类型的生物医学知识库整合到精准医学临床决策支持信息检索系统中的应用。
J Biomed Inform. 2019 Oct;98:103238. doi: 10.1016/j.jbi.2019.103238. Epub 2019 Jul 10.
3
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.在 U-PGx 项目中的药物基因组学决策支持:来自七个欧洲国家临床实施的结果和建议。
PLoS One. 2022 Jun 8;17(6):e0268534. doi: 10.1371/journal.pone.0268534. eCollection 2022.
4
Clinical decision support models and frameworks: Seeking to address research issues underlying implementation successes and failures.临床决策支持模型和框架:旨在解决实施成功和失败背后的研究问题。
J Biomed Inform. 2018 Feb;78:134-143. doi: 10.1016/j.jbi.2017.12.005. Epub 2017 Dec 12.
5
To Share is Human! Advancing Evidence into Practice through a National Repository of Interoperable Clinical Decision Support.分享是人类的天性!通过国家可互操作的临床决策支持知识库推进证据转化为实践。
Appl Clin Inform. 2020 Jan;11(1):112-121. doi: 10.1055/s-0040-1701253. Epub 2020 Feb 12.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Sharing clinical decisions for multimorbidity case management using social network and open-source tools.利用社交网络和开源工具共享多病症管理的临床决策。
J Biomed Inform. 2013 Dec;46(6):977-84. doi: 10.1016/j.jbi.2013.06.007. Epub 2013 Jun 25.
8
Implementation of workflow engine technology to deliver basic clinical decision support functionality.实现工作流引擎技术,以提供基本的临床决策支持功能。
BMC Med Res Methodol. 2011 Apr 10;11:43. doi: 10.1186/1471-2288-11-43.
9
Development and dissemination of clinical decision support across institutions: standardization and sharing of refugee health screening modules.跨机构的临床决策支持的开发和传播:难民健康筛查模块的标准化和共享。
J Am Med Inform Assoc. 2019 Dec 1;26(12):1515-1524. doi: 10.1093/jamia/ocz124.
10
Integrating pharmacogenomics into electronic health records with clinical decision support.将药物基因组学与临床决策支持系统整合到电子健康记录中。
Am J Health Syst Pharm. 2016 Dec 1;73(23):1967-1976. doi: 10.2146/ajhp160030.

引用本文的文献

1
Early peripheral vascular intervention for treating patients with claudication: A decision analysis using national administrative claims data.早期外周血管介入治疗间歇性跛行患者:一项使用国家行政索赔数据的决策分析
Surgery. 2025 Aug 8;186:109589. doi: 10.1016/j.surg.2025.109589.
2
Exploring the adaptation of the Nephroblastoma Oncosimulator to MRI scans, treatment data, and histological profiles of patients from different risk groups.探索肾母细胞瘤肿瘤模拟器对来自不同风险组患者的MRI扫描、治疗数据和组织学特征的适应性。
Front Physiol. 2025 Apr 17;16:1465631. doi: 10.3389/fphys.2025.1465631. eCollection 2025.
3
Use of Real-World FHIR Data Combined with Context-Sensitive Decision Modeling to Guide Sentinel Biopsy in Melanoma.

本文引用的文献

1
Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data.抗血管生成治疗下血管肿瘤生长的数值模拟:利用实验数据探讨单药贝伐单抗治疗的范例
Biol Direct. 2016 Mar 22;11(1):12. doi: 10.1186/s13062-016-0114-9.
2
p-medicine: A Medical Informatics Platform for Integrated Large Scale Heterogeneous Patient Data.p-医学:一个用于整合大规模异构患者数据的医学信息学平台。
AMIA Annu Symp Proc. 2014 Nov 14;2014:872-81. eCollection 2014.
3
Knowledge bases, clinical decision support systems, and rapid learning in oncology.
利用真实世界的FHIR数据结合上下文敏感决策模型指导黑色素瘤前哨活检
J Clin Med. 2024 Jun 6;13(11):3353. doi: 10.3390/jcm13113353.
4
A Multidisciplinary Hyper-Modeling Scheme in Personalized In Silico Oncology: Coupling Cell Kinetics with Metabolism, Signaling Networks, and Biomechanics as Plug-In Component Models of a Cancer Digital Twin.个性化计算机肿瘤学中的多学科超建模方案:将细胞动力学与代谢、信号网络和生物力学耦合,作为癌症数字孪生的插件组件模型。
J Pers Med. 2024 Apr 29;14(5):475. doi: 10.3390/jpm14050475.
5
Cancer drug sensitivity estimation using modular deep Graph Neural Networks.使用模块化深度图神经网络进行癌症药物敏感性估计。
NAR Genom Bioinform. 2024 Apr 27;6(2):lqae043. doi: 10.1093/nargab/lqae043. eCollection 2024 Jun.
6
Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction.在体外进行预训练并对患者来源的数据进行微调可改进用于抗癌药物敏感性预测的深度神经网络。
Cancers (Basel). 2022 Aug 16;14(16):3950. doi: 10.3390/cancers14163950.
7
Learning dynamic treatment strategies for coronary heart diseases by artificial intelligence: real-world data-driven study.通过人工智能学习冠心病的动态治疗策略:基于真实世界数据的研究。
BMC Med Inform Decis Mak. 2022 Feb 15;22(1):39. doi: 10.1186/s12911-022-01774-0.
8
Matching anticancer compounds and tumor cell lines by neural networks with ranking loss.利用带排序损失的神经网络匹配抗癌化合物与肿瘤细胞系。
NAR Genom Bioinform. 2022 Jan 14;4(1):lqab128. doi: 10.1093/nargab/lqab128. eCollection 2022 Mar.
9
Fostering Palliative Care Through Digital Intervention: A Platform for Adult Patients With Hematologic Malignancies.通过数字干预促进姑息治疗:血液系统恶性肿瘤成年患者的一个平台
Front Digit Health. 2021 Dec 17;3:730722. doi: 10.3389/fdgth.2021.730722. eCollection 2021.
10
Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics.迈向模型驱动的临床肿瘤学的多尺度癌症系统生物学及其在个性化治疗中的应用
Front Oncol. 2021 Nov 24;11:712505. doi: 10.3389/fonc.2021.712505. eCollection 2021.
知识库、临床决策支持系统与肿瘤学中的快速学习
J Oncol Pract. 2015 Mar;11(2):e206-11. doi: 10.1200/JOP.2014.000620. Epub 2015 Feb 24.
4
Improving the implementation of clinical decision support systems.改善临床决策支持系统的实施情况。
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:3214-7. doi: 10.1109/EMBC.2013.6610225.
5
The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context.技术集成的肿瘤模拟器:在计算机肿瘤学背景下将多尺度癌症建模与信息技术相结合。
IEEE J Biomed Health Inform. 2014 May;18(3):840-54. doi: 10.1109/JBHI.2013.2284276. Epub 2013 Oct 2.
6
The Evidence-base for Using Ontologies and Semantic Integration Methodologies to Support Integrated Chronic Disease Management in Primary and Ambulatory Care: Realist Review. Contribution of the IMIA Primary Health Care Informatics WG.使用本体和语义整合方法支持初级和门诊医疗中慢性病综合管理的循证依据:实证性综述。IMIA初级卫生保健信息学工作组的贡献。
Yearb Med Inform. 2013;8:147-54.
7
FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.FOXO3a 是侵袭性神经母细胞瘤中 PI3K/AKT 信号失活的主要靶标。
Cancer Res. 2013 Apr 1;73(7):2189-98. doi: 10.1158/0008-5472.CAN-12-3767. Epub 2013 Feb 1.
8
Towards in silico oncology: adapting a four dimensional nephroblastoma treatment model to a clinical trial case based on multi-method sensitivity analysis.迈向计算机肿瘤学:基于多方法敏感性分析,将一个四维肾母细胞瘤治疗模型应用于临床试验案例。
Comput Biol Med. 2012 Nov;42(11):1064-78. doi: 10.1016/j.compbiomed.2012.08.008. Epub 2012 Oct 10.
9
MicroRNAs in breast cancer initiation and progression.微小 RNA 在乳腺癌发生和发展中的作用。
Cell Mol Life Sci. 2012 Nov;69(21):3587-99. doi: 10.1007/s00018-012-1128-9. Epub 2012 Aug 28.
10
Treatment-independent miRNA signature in blood of Wilms tumor patients.Wilms 瘤患者血液中治疗独立性 miRNA 特征。
BMC Genomics. 2012 Aug 7;13:379. doi: 10.1186/1471-2164-13-379.